Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonistic CTLA-4 aptamers and applications thereof in enhancing immune activity

Antagonistic CTLA-4 aptamers and applications thereof in enhancing immune activity

US Patent 10533179 · Granted Jan 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pipeline, pipeline connector, and liquid chromatography system2025
Methods of using 4(1H)-quinolone derivatives2024
Biomarkers for lung cancer stem cells2024
Metasurface based device for generating abrupt autofocusing beam2024
4,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives and uses ther2024
Method for treating cancer using CD14 antagonists2024
Method for identifying anti-cancer agents using an in vitro cell culture system 2023
4(1H)-quinolone derivatives and uses thereof2023
TNF-targeting aptamers and uses thereof for treatment or diagnosing TNF-related 2022
4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-3-carboxamide derivatives and uses ther2022
PINK1 C-terminal domain polypeptide and methods using the same in cancer treatme2022
PINK1 C-terminal domain polypeptide and methods using the same in cancer treatme2022